Active, not recruitingNot applicableNCT06271044

a. Reducing Radioiodine Treatment in Papillary Thyroid Cancer. RAILESS

Studying Adenocarcinoma of the cervix uteri

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Helsinki University Central Hospital
Principal Investigator
Päivi Halonen, MD
Medical Oncologist
Intervention
With radioiodine treatment(other)
Enrollment
61 target
Eligibility
18-85 years · All sexes
Timeline
20142027

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06271044 on ClinicalTrials.gov

Other trials for Adenocarcinoma of the cervix uteri

Additional recruiting or active studies for the same condition.

See all trials for Adenocarcinoma of the cervix uteri

← Back to all trials